These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 36702360)

  • 1. Modulating the Microbiome for Crohn's Disease Treatment.
    Gowen R; Gamal A; Di Martino L; McCormick TS; Ghannoum MA
    Gastroenterology; 2023 Apr; 164(5):828-840. PubMed ID: 36702360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's Disease, Host-Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches.
    Núñez-Sánchez MA; Melgar S; O'Donoghue K; Martínez-Sánchez MA; Fernández-Ruiz VE; Ferrer-Gómez M; Ruiz-Alcaraz AJ; Ramos-Molina B
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics and Host-Tailored Probiotics Similarly Modulate Effects on the Developing Avian Microbiome, Mycobiome, and Host Gene Expression.
    Ward TL; Weber BP; Mendoza KM; Danzeisen JL; Llop K; Lang K; Clayton JB; Grace E; Brannon J; Radovic I; Beauclaire M; Heisel TJ; Knights D; Cardona C; Kogut M; Johnson C; Noll SL; Arsenault R; Reed KM; Johnson TJ
    mBio; 2019 Oct; 10(5):. PubMed ID: 31615957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.
    Rashed R; Valcheva R; Dieleman LA
    Front Med (Lausanne); 2022; 9():887044. PubMed ID: 35783604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
    Khanna S; Raffals LE
    Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics and prebiotics in Crohn's disease therapies.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
    De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
    Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
    Ciernikova S; Sevcikova A; Drgona L; Mego M
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
    Yadav A; Yadav R; Sharma V; Dutta U
    Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The triple interactions between gut microbiota, mycobiota and host immunity.
    Yang J; Yang H; Li Y
    Crit Rev Food Sci Nutr; 2023 Nov; 63(33):11604-11624. PubMed ID: 35776086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
    Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut microbiota as a therapeutic target for obesity: a scoping review.
    Santos-Paulo S; Costello SP; Forster SC; Travis SP; Bryant RV
    Nutr Res Rev; 2022 Dec; 35(2):207-220. PubMed ID: 34100344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prebiotic and Probiotic Modulation of the Microbiota-Gut-Brain Axis in Depression.
    Radford-Smith DE; Anthony DC
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering Strategies to Modulate the Gut Microbiome and Immune System.
    Han K; Xu J; Xie F; Crowther J; Moon JJ
    J Immunol; 2024 Jan; 212(2):208-215. PubMed ID: 38166246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome-based interventions to modulate gut ecology and the immune system.
    Hitch TCA; Hall LJ; Walsh SK; Leventhal GE; Slack E; de Wouters T; Walter J; Clavel T
    Mucosal Immunol; 2022 Jun; 15(6):1095-1113. PubMed ID: 36180583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal symptoms, gut microbiome, probiotics and prebiotics in anorexia nervosa: A review of mechanistic rationale and clinical evidence.
    Dhopatkar N; Keeler JL; Mutwalli H; Whelan K; Treasure J; Himmerich H
    Psychoneuroendocrinology; 2023 Jan; 147():105959. PubMed ID: 36327759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microbiome landscape in pediatric Crohn's disease and therapeutic implications.
    Fetter K; Weigel M; Ott B; Fritzenwanker M; Stricker S; de Laffolie J; Hain T
    Gut Microbes; 2023 Dec; 15(2):2247019. PubMed ID: 37614093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
    Eindor-Abarbanel A; Healey GR; Jacobson K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.